GERON CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.575 USD | +2.14% |
|
-3.12% | +68.96% |
| Mar. 19 | Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants | MT |
| Mar. 15 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Chart calendar Geron Corporation
335a1e8.RoLAoLI96J4u8Ao3lcQApO38wQVj80O2Pd3hYYOVD5Y.DMus6vlcv8t9oEJ75vZX17qJl1MNywvgRKzVFtvASuQQz7To9gukq0i9Sw~153c6164dff8d47a9bf2cd7e4661f932
Upcoming events on Geron Corporation
Past events on Geron Corporation
| 2024-04-17 11:30 am | Stifel Virtual Targeted Oncology Days Conference |
| 2024-04-10 10:15 am | Needham Healthcare Conference |
| 2024-02-28 08:00 am | Q4 2023 Earnings Call |
| 2024-02-28 07:05 am | Q4 2023 Earnings Release |
| 2024-01-18 10:30 am | B. Riley Securities Oncology Conference - Track 1 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract #2440 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract #4603 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract #4605 |
| 2023-12-09 05:15 pm | American Society of Hematology Meeting - Abstract #194 |
| 2023-11-29 10:50 am | Evercore ISI HealthCONx Conference |
| 2023-11-28 09:30 am | Piper Sandler Healthcare Conference |
| 2023-11-14 09:10 am | Stifel Healthcare Conference |
| 2023-11-02 09:00 am | Q3 2023 Earnings Call |
| 2023-11-01 | Q3 2023 Earnings Release Pre-market |
| 2023-09-12 04:55 pm | Baird Global Healthcare Conference |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:00 pm | Q2 2023 Earnings Release |
| 2023-06-15 11:40 am | Goldman Sachs Global Healthcare Conference |
| 2023-06-14 08:00 am | Investor Meeting - Key Opinion Leader |
| 2023-06-11 05:30 am | European Hematology Association Hybrid Congress - Abstract No : #S164 |
Past dividends on Geron Corporation
| 2014-07-21 | 0 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,46 0,36 26.23% | 0,25 0,24 3.62% | 1,39 0,42 228.38% | 0,60 0,61 -2.08% | 0,24 0,30 -19.8% | 54,2 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -194 -201 3.64% | -214 |
|
EBIT Million USD | Released Forecast Spread | -72,5 -82,3 11.9% | -76,9 -74,7 -3.01% | -114 -110 -3.32% | -139 -146 5.33% | -194 -201 3.69% | -218 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,5 -78,6 12.76% | -75,6 -72,0 -5.03% | -116 -111 -4.32% | -142 -149 4.45% | -184 -194 4.88% | -214 |
|
Net income Million USD | Released Forecast Spread | -68,5 -78,9 13.15% | -75,6 -72,7 -4.07% | -116 -112 -4.05% | -142 -150 5.49% | -184 -196 5.97% | -214 |
|
EPS USD | Released Forecast Spread | -0,36 -0,42 14.29% | -0,28 -0,27 -5% | -0,35 -0,34 -2.94% | -0,37 -0,39 4.31% | -0,32 -0,35 7.51% | -0,35 |
| Announcement Date | 12/03/20 | 11/03/21 | 10/03/22 | 16/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,04 0,06 1582.85% | 0,12 0,10 20.29% | 0,07 0,11 -36.3% | 0,30 0,09 240.71% | 0,10 0,12 -17.27% | 0,02 0,08 -73.64% | 0,03 0,08 -63.38% | 0,16 0,07 131.64% | 0,02 0,10 -76.48% | 0,03 | 0,03 | 19,1 | 35,1 | 53,0 |
|
EBIT Million USD | Released Forecast Spread | -31,0 -27,3 -13.39% | -28,7 -34,2 16.27% | -28,0 -34,5 18.82% | -39,9 -37,1 -7.66% | -42,0 -49,7 15.67% | -40,1 -46,4 13.53% | -52,0 -47,0 -10.53% | -47,6 -57,5 17.18% | -54,3 -61,7 12.04% | -59,6 | -66,1 | -52,2 | -40,0 | -43,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,0 -27,2 -17.56% | -30,1 -34,7 13.34% | -28,1 -34,8 19.19% | -41,1 -37,2 -10.46% | -42,6 -49,2 13.4% | -38,1 -47,1 19.14% | -49,2 -46,4 -6.04% | -44,8 -57,3 21.82% | -52,0 -59,5 12.7% | -58,0 | -65,5 | -51,3 | -39,3 | |
|
Net income Million USD | Released Forecast Spread | -32,0 -27,5 -16.34% | -30,1 -35,3 14.63% | -28,1 -35,6 21.05% | -41,1 -38,1 -7.87% | -42,6 -50,9 16.18% | -38,1 -50,4 24.3% | -49,2 -48,7 -1.06% | -44,8 -58,6 23.59% | -52,0 -61,8 15.89% | -57,9 | -65,1 | -51,2 | -40,2 | -41,8 |
|
EPS USD | Released Forecast Spread | -0,10 -0,08 -19.05% | -0,09 -0,11 14.29% | -0,07 -0,09 25.53% | -0,10 -0,09 -7.15% | -0,10 -0,13 20% | -0,07 -0,10 31.37% | -0,09 -0,09 -4.65% | -0,08 -0,10 21.57% | -0,09 -0,10 13.46% | -0,10 | -0,11 | -0,08 | -0,06 | -0,05 |
| Announcement Date | 10/03/22 | 09/05/22 | 11/08/22 | 03/11/22 | 16/03/23 | 11/05/23 | 03/08/23 | 02/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Geron Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GERN Stock
- Calendar Geron Corporation
